Vontobel Holding
ICPT

Vontobel Holding’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Vontobel Holding’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$223K – 1241
2021
Q3 		$223K Hold
15,000
– – ﹤0.01% 1012
2021
Q2 		$300K Hold
15,000
– – ﹤0.01% 917
2021
Q1 		$346K Buy
15,000
+5,000
+50% +$139K ﹤0.01% 756
2020
Q4 		$247K Buy
+10,000
New +$331K ﹤0.01% 852

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Vontobel Holding's ICPT Position: Q4 2021 in Review

Vontobel Holding sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 15,000 shares — an estimated $223K sold.

Vontobel Holding first reported a position in ICPT in Q4 2020 and held it in 4 quarters. The position peaked at $346K in Q1 2021. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

  • Vontobel Holding reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Vontobel Holding sold 15,000 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $223K.
  • Vontobel Holding first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 4 quarters.
  • Vontobel Holding's Intercept Pharmaceuticals, Inc. position peaked at $346K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on Vontobel Holding's 13F filing for Q4 2021, filed 10 Feb 2022.